Commercial risk management in the health environment: exploring the legal and ethical boundaries of consent in genetic diagnostic research. There is little empirical research on consent in clinical research, particularly genetic diagnostic testing, despite its key significance to risk management in medical research practice. This study analyses consent procedures of clinicians and researchers for individual research participants. Key clinicians and Laboratory Heads engaged in genetic diagnostic ....Commercial risk management in the health environment: exploring the legal and ethical boundaries of consent in genetic diagnostic research. There is little empirical research on consent in clinical research, particularly genetic diagnostic testing, despite its key significance to risk management in medical research practice. This study analyses consent procedures of clinicians and researchers for individual research participants. Key clinicians and Laboratory Heads engaged in genetic diagnostic research will be interviewed and consent forms assessed. This will produce identification of trends in consent procedures and baseline information for national studies. The significance is the priority accorded genetic research, the need for adequate risk management in that context and development of optimal consent procedures and policy at State and National levels.Read moreRead less
Just Rules for Incentivizing Pharmaceutical Research and for Disseminating its Benefits. Intelligent reform of the rules for incentivizing pharmaceutical research and for disseminating its benefits can cost-effectively decimate the global disease burden. Australians would benefit directly, through lower drug prices, enhanced pharmaceutical research employment, and improved public health, as well as indirectly, through reduced threats from foreign diseases and better relations with the developing ....Just Rules for Incentivizing Pharmaceutical Research and for Disseminating its Benefits. Intelligent reform of the rules for incentivizing pharmaceutical research and for disseminating its benefits can cost-effectively decimate the global disease burden. Australians would benefit directly, through lower drug prices, enhanced pharmaceutical research employment, and improved public health, as well as indirectly, through reduced threats from foreign diseases and better relations with the developing countries.Read moreRead less